MedPath
NMPA Approval

Olopatadine Hydrochloride Eye Drops

国药准字H20244478

July 22, 2024

Drug Information

盐酸奥洛他定滴眼液

眼用制剂

0.1%(5ml:5mg,以C₂₁H₂₃NO₃计)

化学药品

July 22, 2024

Company Information

Applicant Company

四川绵竹经济开发区江苏工业园镇江路1号

Manufacturing Company

四川绵竹经济开发区江苏工业园镇江路1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.